Full history for every metric is available with a Kvantra account

Stock profile
EBR Systems, Inc. logo

EBR Systems, Inc. (EBR.AX)

Country: United States of AmericaSector: HealthcareIndustry: Medical - DevicesExchange: ASX
P/E TTM
N/A
History
P/E NTM
N/A
Market cap
117.68M
Currency AUD
KvantraRankAbout12
IValue26
IIQuality5
IIIMomentum1
Current price
0.26 AUD-1.89%
Close 2 Oct 2026
Benchmarks

Key financial summary

Financials in USDTTM unavailable
202020212022202320242025TTM
Total revenue$m000002-
Operating profit$m-48-
Net profit$m-0-0-33-35-20-50-
EPS reported$-0.12-
Operating cashflow per share$-0.13-
Capex per share$0.01-
FCF per share$-0.14-
Free cash flow$m-59-
Net debt$m-11-
Book value equity$m26-
Book value per share$0.06-
Number of sharesm417.33-
DPS (TTM paid)$0.00-

Financial summary

Financials in USDTTM unavailable
202020212022202320242025TTM
Value
P/E TTMx--
P/B LTMx9.73-
P/S LTMx148.94-
P/FCF LTMx-4.23-
EV/EBITDA LTMx-6.39-
EV/Sales LTMx180.51-
Earnings Yield LTM%-20.24%-
FCF Yield%-23.61%-
Quality
ROE%-197.06%-
ROIC%-56.50%-
Operating margin%-2850.2%-
Gross margin%30.30%-
FCF/Sales%-3517.3%-
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%--
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%-
Dividend Growth%0.00%-
Payout Ratio%0.00%-
FCF/Debtx-1.00-
Net Debt/EBITDAx-1.12-
EBIT/Net interestx-8.17-
Net debt/market cap%-4.46%-
Net debt/Equityx-0.43-
Gross debt/equityx2.29-

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price0.26 AUD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique wireless method to deliver pacing signals directly inside the left ventricle of the heart. This innovative approach helps overcome the typical challenges linked to traditional pacing leads, including complex insertion, inadvertent nerve activation, displacement, removal procedures, and subsequent adjustments. Established in 2003, the company operates out of Sunnyvale, California.

IndustryMedical - Devices
Trades inAUD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

EBR Systems, Inc. (EBR.AX)

EBR.AX · ASX · Healthcare
0.26 AUD-1.89%
Sign up to track this stock
Benchmarks
KvantraRank12
Market cap117.68M
P/E NTMN/A
P/E TTMN/A
KvantraRank?12 / 100
Value
26
Quality
5
Momentum
1
Financialsin USD
TTM unavailable.
20242025TTM
Analyst target
Consensus
Current0.26 AUD
Upside
Price consensus
Last year average price target
Current price0.26 AUD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

EBR Systems, Inc. is a company focused on creating implantable medical devices that employ wireless technology for tissue stimulation. Their flagship product is the WiSE cardiac resynchronization therapy system, which utilizes a unique wireless method to deliver pacing signals directly inside the left ventricle of the heart. This innovative approach helps overcome the typical challenges linked to traditional pacing leads, including complex insertion, inadvertent nerve activation, displacement, removal procedures, and subsequent adjustments. Established in 2003, the company operates out of Sunnyvale, California.

IndustryMedical - Devices
Trades inAUD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free